Dianthus Therapeutics | MGTA - Ativo Circulante





Ativo Circulante Alterar Data
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
Avita Medical AUD 35.49M 760K 2025-12
Celltrion KRW 481.57B 10.97B 2026-03
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
IQVIA Holdings USD 6.23B 6M 2026-06
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 5.82B 45M 2026-06
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 250.09M 6.46M 2026-03
Organon & Co USD 5.11B 179M 2026-06
Ovoca Bio EUR 2.07M 510K 2025-12
Pharma Mar EUR 280.95M 7.5M 2026-06
Qiagen NV USD 1.66B 116.37M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Sartorius EUR 1.64B 280M 2026-06
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Tilray USD 729.32M 28.18M 2025-09
Viatris USD 10.06B 861.1M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 11.16B 270.46M 2026-06